Skip to main content
Log in

Role of echocardiography and cardiac MRI in depicting morphological and functional imaging findings useful for diagnosing hypertrophic cardiomyopathy

Ruolo dell’eco-cardiografia e della cardio-RM nella definizione dei rilievi morfologici e funzionali utili nella diagnosi di cardiomiopatia ipertrofica

  • Cardiac Radiology / Cardioradiologia
  • Published:
La radiologia medica Aims and scope Submit manuscript

Abstract

Purpose

Hypertrophic cardiomyopathy (HCM) is a hereditary disease characterised by primary hypertrophy of the left and/or right ventricle. The reference standard for imaging diagnosis is echocardiography. The aim of our study was to prospectively compare the diagnostic accuracy of echocardiography and cardiac magnetic resonance (MR) imaging in patients with HCM.

Materials and methods

Twenty-two consecutive patients with a known diagnosis of HCM were prospectively evaluated, with echocardiography and cardiac MR imaging performed within 2 weeks of each other (mean interval 7 days, range 2–14 days). Two experienced radiologists blinded to the previous clinical and imaging findings separately reviewed the images. The following parameters were calculated for both techniques: myocardial mass, wall thickness, end-diastolic volume (EDV), end-systolic volume (ESV), ejection fraction (EF), systolic anterior motion (SAM) of the mitral valve and degree of myocardial fibrosis (based on the ultrasonic reflectivity at echocardiography and degree of late enhancement at cardiac MR imaging). The statistical correlation was calculated with Student’s t test, Spearman coefficient and Fisher’s exact test. A value of p<0.05 was considered significant.

Results

The diagnosis of HCM was confirmed in all patients with both techniques, with absolute agreement in terms of the site of disease. The mean value of myocardial mass presented a statistically significant difference between the two techniques (114 g, p<0.001). In contrast, a nonsignificant difference between echocardiography and cardiac MR imaging was found for EDV (102 ml vs 111 ml; p=0.31), ESV (30 ml vs 38 ml; p=0.1), EF (74% vs 68%, p=0.5), SAM (p=0.1) and myocardial fibrosis (p=0.15).

Conclusions

Cardiac MR imaging correlates well with echocardiography in defining the morphological and functional parameters useful for the imaging diagnosis of HCM and therefore, in selected cases (poor acoustic window, doubtful echocardiography findings), it may be a valid alternative to echocardiography.

Riassunto

Obiettivo

La cardiomiopatia ipertrofica (CMI) è una malattia ereditaria caratterizzata dalla primitiva ipertrofia del ventricolo sinistro e/o destro. Lo standard di riferimento per la diagnosi strumentale è rappresentato dall’eco-cardiografia. Il nostro scopo è confrontare prospetticamente l’accuratezza diagnostica di ecocardiografia e risonanza magnetica cardiaca (cardio-RM) in pazienti con CMI.

Materiali e metodi

Ventidue pazienti consecutivi con diagnosi nota di CMI sono stati prospetticamente valutati mediante eco-cardiografia e cardio-RM eseguite entro 2 settimane (scarto medio 7 giorni, range 2–14 giorni). Due operatori esperti, non a conoscenza dei precedenti dati clinici e strumentali dei pazienti arruolati, hanno revisionato separatamente le immagini. Per entrambe le tecniche sono stati calcolati massa cardiaca, spessori di parete, volume telediastolico (VTD) e telesistolico (VTS), frazione di eiezione (FE), spostamento anteriore del lembo mitralico (SAM), grado di fibrosi parietale (basato sul valore di eco-rinfrangenza all’eco-cardiografia e sull’entità di impregnazione tardiva alla cardio-RM). La correlazione statistica è stata calcolata mediante test t di Student, R di Spearman e test di Fisher. Un valore di p<0,05 è stato considerato significativo.

Risultati

La diagnosi di CMI è stata confermata in tutti i pazienti con entrambe le metodiche, con concordanza assoluta per quanto riguarda la sede. Il valore medio della massa cardiaca ha presentato una differenza statisticamente significativa tra le due metodiche (114 g, p<0,001). Al contrario, una differenza non significativa fra eco-cardiografia e cardio-RM è stata riscontrata per i valori di VTD (102 ml vs 111 ml; p=0,31), VTS (30 ml vs 38 ml; p=0,1), frazione d’eiezione (74% vs 68%, p=0,5), SAM (p=0,1), fibrosi parietale (p=0,15).

Conclusioni

La cardio-RM correla bene con l’ecocardiografia nella definizione dei parametri morfologici e funzionali utili per la diagnosi strumentale di CMI e può pertanto rappresentare, in casi selezionati (scarsa finestra acustica, rilievi eco-cardiografici dubbi), una valida alternativa all’eco-cardiografia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References/Bibliografia

  1. Wigle ED, Rakowski H, Kimball BP et al (1995) Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation 92:1680–1692

    PubMed  CAS  Google Scholar 

  2. Maron BJ, Gardin JM, Flack JM et al (1995) Prevalence of hypertrophic cardiomyopathy in a population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Coronary Artery Risk Development in (young) adults. Circulation 92:785–789

    PubMed  CAS  Google Scholar 

  3. Jarcho JA, McKena WJ, Pare JA et al (1989) Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. N Engl J Med 321:1372–1378

    Article  PubMed  CAS  Google Scholar 

  4. Pellnitz C, Geier C, Perrot A et al (2005) Sudden cardiac death in familial hypertrophic cardiomyopathy. Identification of high-risk patients. Dtsch Med Wochenschr 130:1150–1154

    Article  PubMed  CAS  Google Scholar 

  5. Syed IS, Ommen SR, Breen JF et al (2008) Hypertrophic cardiomyopathy: identification of morphological subtypes by echocardiography and cardiac magnetic resonance imaging. JACC Cardiovasc Imaging 1:377–379

    Article  PubMed  Google Scholar 

  6. Tam JW, Shaikh N, Sutherland E (2002) Echocardiographic assessment of patients with hypertrophic and restrictive cardiomyopathy: imaging and echocardiography. Curr Opin Cardiol. 17:470–477

    Article  PubMed  Google Scholar 

  7. Earls JP, Ho VB, Foo TK et al (2002) Cardiac MRI: recent progress and continued challenges. J Magn Reson Imaging 16:111–127

    Article  PubMed  Google Scholar 

  8. Bicudo LS, Tsutsui JM, Shiozaki A et al (2008) Value of real time three-dimensional echocardiography in patients with hypertrophic cardiomyopathy: comparison with two-dimensional echocardiography and magnetic resonance imaging. Echocardiography 25:717–726

    Article  PubMed  Google Scholar 

  9. Aquaro GD, Masci P, Formisano F et al (2010) Usefulness of delayed enhancement by magnetic resonance imaging in hypertrophic cardiomyopathy as a marker of disease and its severity. Am J Cardiol 105:392–397

    Article  PubMed  Google Scholar 

  10. Payá E, Marín F, González J et al (2008) Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications. J Card Fail 14:414–419

    Article  PubMed  Google Scholar 

  11. Dimitrow PP, Klimeczek P, Vliegenthart R et al (2008) Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging: comparison of hypertrophic cardiomyopathy patients with and without nonsustained ventricular tachycardia. Int J Cardiovasc Imaging 24:77–83

    Article  PubMed  Google Scholar 

  12. Rubinshtein R, Glockner JF, Ommen SR et al (2010) Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail 3:51–58

    Article  PubMed  Google Scholar 

  13. Kwon DH, Smedira NG, Rodriguez ER et al (2009) Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. J Am Coll Cardiol 54:242–249

    Article  PubMed  Google Scholar 

  14. Weyman AE (1994) Principals and practice of echocardiography. Lea & Febiger, Philadelphia

    Google Scholar 

  15. Afonso LC, Bernal J, Bax JJ, Abraham TP (2008) Echocardiography in hypertrophic cardiomyopathy: the role of conventional and emerging technologie. JACC Cardiovasc Imaging 1:787–800

    Article  PubMed  Google Scholar 

  16. Carsten R, Norbert M, Michael J et al (2005) Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 112:855–861

    Article  Google Scholar 

  17. Fattori R, Biagini E, Lorenzini M et al (2010) Significance of magnetic resonance imaging in apical hypertrophic cardiomyopathy. Am J Cardiol 105:1592–1596

    Article  PubMed  Google Scholar 

  18. Moon JC, Fisher NG, McKenna WJ et al (2004) Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 90:645–649

    Article  PubMed  CAS  Google Scholar 

  19. Marcus JT, Götte MJ, DeWaal LK et al (1998) The influence of through-plane motion on left ventricular volumes measured by magnetic resonance imaging: implications for image acquisition and analysis. J Cardiovasc Magn Reson 1:1–6

    Article  Google Scholar 

  20. Kwon DH, Desai MY (2010) Cardiac magnetic resonance in hypertrophic cardiomyopathy: current state of the art. Expert Rev Cardiovasc Ther 8:103–111

    Article  PubMed  Google Scholar 

  21. Factor SM, Butany J, Sole MJ et al (2000) Pathologic fibrosis and matrix connective tissue in the subaortic myocardium of patiens with hypertrophic cardiomyopathy. J Am Coll Cardiol 35:36–44

    Article  Google Scholar 

  22. Esposito A, De Cobelli F, Perseghin G et al (2009) Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging. Heart 95:228–233

    Article  PubMed  CAS  Google Scholar 

  23. Bergey PD, Axel L (2000) Focal hypertrophic cardiomyopathy simulating a mass: MR tagging for correct diagnosis. AJR Am J Roentgenol 174:242–244

    PubMed  CAS  Google Scholar 

  24. Ligabue G, Fiocchi F, Ferraresi S et al (2008) 3-Tesla MRI for the evaluation of myocardial viability: a comparative study with 1.5-Tesla MRI. Radiol Med 113:347–362

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Guarise.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guarise, A., Faccioli, N., Foti, G. et al. Role of echocardiography and cardiac MRI in depicting morphological and functional imaging findings useful for diagnosing hypertrophic cardiomyopathy. Radiol med 116, 197–210 (2011). https://doi.org/10.1007/s11547-010-0603-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11547-010-0603-3

Keywords

Parole chiave

Navigation